Alpha Cubed Investments’s Bristol-Myers Squibb BMY Stock Holding History

Alpha Cubed Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$722K	Hold	13,383	–	–	0.02%	146
2025 Q3	$604K	Sell	13,383 -3,255	-20%	-$152K	0.02%	158
2025 Q2	$770K	Buy	16,638 +1,082	+7%	+$53.1K	0.03%	136
2025 Q1	$949K	Buy	+15,556	New	+$907K	0.04%	122
2024 Q4	–	Sell	-4,404	Closed	-$228K	–	270
2024 Q3	$228K	Sell	4,404 -553	-11%	-$25.9K	0.01%	235
2024 Q2	$206K	Buy	4,957 +624	+14%	+$27.9K	0.01%	269
2024 Q1	$235K	Buy	+4,333	New	+$221K	0.01%	240
2023 Q4	–	Sell	-10,788	Closed	-$626K	–	284
2023 Q3	$626K	Sell	10,788 -2,711	-20%	-$166K	0.04%	123
2023 Q2	$863K	Sell	13,499 -267	-2%	-$17.9K	0.06%	115
2023 Q1	$954K	Sell	13,766 -2,927	-18%	-$206K	0.07%	109
2022 Q4	$1.2M	Buy	16,693 +700	+4%	+$52.8K	0.09%	107
2022 Q3	$1.14M	Sell	15,993 -11,626	-42%	-$843K	0.09%	105
2022 Q2	$2.13M	Buy	27,619 +125	+0.5%	+$9.52K	0.15%	87
2022 Q1	$2.01M	Buy	27,494 +16,553	+151%	+$1.11M	0.13%	98
2021 Q4	$682K	Buy	10,941 +5,742	+110%	+$337K	0.04%	146
2021 Q3	$308K	Sell	5,199 -3,102	-37%	-$204K	0.02%	211
2021 Q2	$555K	Hold	8,301	–	–	0.04%	155
2021 Q1	$524K	Sell	8,301 -1,479	-15%	-$92K	0.04%	154
2020 Q4	$607K	Sell	9,780 -4,161	-30%	-$256K	0.05%	142
2020 Q3	$841K	Sell	13,941 -596	-4%	-$35.9K	0.08%	107
2020 Q2	$855K	Buy	14,537 +4,451	+44%	+$266K	0.09%	95
2020 Q1	$562K	Buy	10,086 +637	+7%	+$38.9K	0.07%	111
2019 Q4	$607K	Buy	9,449 +5,102	+117%	+$292K	0.06%	125
2019 Q3	$220K	Sell	4,347 -190	-4%	-$8.93K	0.03%	225
2019 Q2	$206K	Sell	4,537 -892	-16%	-$41.5K	0.02%	237
2019 Q1	$259K	Sell	5,429 -839	-13%	-$41.8K	0.03%	188
2018 Q4	$326K	Sell	6,268 -11,838	-65%	-$636K	0.05%	150
2018 Q3	$983K	Buy	18,106 +7,562	+72%	+$449K	0.11%	111
2018 Q2	$584K	Buy	10,544 +524	+5%	+$28.3K	0.08%	109
2018 Q1	$634K	Sell	10,020 -34	-0.3%	-$2.19K	0.08%	112
2017 Q4	$616K	Buy	10,054 +1,067	+12%	+$66.7K	0.08%	118
2017 Q3	$573K	Buy	8,987 +370	+4%	+$21.6K	0.09%	119
2017 Q2	$480K	Sell	8,617 -8,537	-50%	-$465K	0.08%	117
2017 Q1	$933K	Sell	17,154 -148,145	-90%	-$8.13M	0.19%	73
2016 Q4	$9.66M	Buy	165,299 +152,978	+1,242%	+$8.36M	2.32%	10
2016 Q3	$664K	Buy	12,321 +7,835	+175%	+$503K	0.18%	83
2016 Q2	$330K	Sell	4,486 -1,410	-24%	-$99.6K	0.11%	104
2016 Q1	$377K	Sell	5,896 -921	-14%	-$58.1K	0.12%	108
2015 Q4	$469K	Buy	6,817 +233	+4%	+$15.4K	0.12%	115
2015 Q3	$434K	Buy	6,584 +1,600	+32%	+$102K	0.11%	126
2015 Q2	$332K	Hold	4,984	–	–	0.09%	143
2015 Q1	$321K	Buy	4,984 +1,384	+38%	+$86.6K	0.1%	139
2014 Q4	$213K	Sell	3,600 -400	-10%	-$22.6K	0.08%	131
2014 Q3	$205K	Sell	4,000 -2,867	-42%	-$143K	0.1%	138
2014 Q2	$333K	Sell	6,867 -201	-3%	-$9.9K	0.15%	141
2014 Q1	$367K	Sell	7,068 -3,323	-32%	-$177K	0.19%	126
2013 Q4	$552K	Buy	+10,391	New	+$529K	0.2%	143

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Alpha Cubed Investments's BMY Position: Q4 2025 in Review

Alpha Cubed Investments held its Bristol-Myers Squibb (BMY) position steady in Q4 2025 at 13,383 shares worth $722K. The position accounts for 0.02% of the portfolio, ranked #146.

Alpha Cubed Investments first reported a position in BMY in Q4 2013 and has held it in 47 quarters since. The position peaked at $9.66M in Q4 2016. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Alpha Cubed Investments held 13,383 shares of Bristol-Myers Squibb worth $722K as of Q4 2025.
Alpha Cubed Investments left its Bristol-Myers Squibb share count unchanged in Q4 2025.
Bristol-Myers Squibb made up 0.02% of Alpha Cubed Investments's portfolio in Q4 2025, its #146 holding.
Alpha Cubed Investments first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 47 quarters since.
Alpha Cubed Investments's Bristol-Myers Squibb position peaked at $9.66M in Q4 2016.
2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Alpha Cubed Investments's 13F filing for Q4 2025, filed 3 Feb 2026.